Downregulation of MicroRNA-145 caused by Hepatitis B Virus X protein promotes expression of CUL5 and contributes to pathogenesis of Hepatitis B virus-associated hepatocellular carcinoma

Cellular Physiology and Biochemistry

Volumn 37, Issue 4, 2015, Pages 1547-1559

  Gao, Feng ^a   Sun, Xiaoyu ^b   Wang, Likun ^a   Tang, Shunxiong ^c   Yan, Changqing ^d  

^a SHANDONG UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c DALIAN UNIVERSITY   (China)

^d HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; CUL5; HBX; HCC; MiR 145

Indexed keywords

CULLIN; CULLIN 5; HEPATITIS B VIRUS X PROTEIN; MESSENGER RNA; MICRORNA 145; PROTEIN; RAB PROTEIN; RAB5C PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ANTISENSE OLIGONUCLEOTIDE; CUL5 PROTEIN, HUMAN; MICRORNA; MIRN145 MICRORNA, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; HEPATITIS B; HEPATITIS B VIRUS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS CARCINOGENESIS; 3' UNTRANSLATED REGION; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINT; COMPLICATION; GENETICS; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; SEQUENCE ALIGNMENT; TUMOR CELL LINE; VIROLOGY;

3' UNTRANSLATED REGIONS; ADULT; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CULLIN PROTEINS; DOWN-REGULATION; FEMALE; HEP G2 CELLS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDES, ANTISENSE; SEQUENCE ALIGNMENT; TRANS-ACTIVATORS;

EID: 84945585704     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000438522     Document Type: Article

References (46)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576.
2. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118-112.
3. Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F, Qiu G, Xie K. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Int J Oncol 2005;26:467-473.
4. Yun C, Cho H, Kim SJ, Lee JH, Park SY, Chan GK, Cho H. Mitotic aberration coupled with centrosome amplification is induced by hepatitis B virus X oncoprotein via the Ras-mitogen-Activated protein/extracellular signal-regulated kinase-mitogen-Activated protein pathway. Mol Cancer Res 2004;2:159-169.
5. Wu JY, Zhou ZY, Judd A, Cartwright CA, Robinson WS. The hepatitis B virus-encoded transcriptional trans-Activator hbx appears to be a novel protein serine/threonine kinase. Cell 1990;63:687-695.
6. Liang TJ. Hepatitis B: the virus and disease. Hepatology 2009;49:S13-21.
7. Cha MY, Ryu DK, Jung HS, Chang HE, Ryu WS. Stimulation of hepatitis B virus genome replication by HBx is linked to both nuclear and cytoplasmic HBx expression. J Gen Virol 2009;90:978-986.
8. Yang B and Bouchard MJ. The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake. J Virol 2012;86:313-327.
9. Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, Wu FQ, Zhang HL, Yu LX, Zheng LY, Li YQ, Dong W, He YQ, Liu Q, Zou SS, Lin Y, Hu L, Li Z, Wu MC, Wang HY. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3, 5-diethoxycarbonyl-1, 4-dihydrocollidine-Dreated HBx transgenic mice. Hepatology 2012;55:108-120.
10. Arzumanyan A, Sambandam V, Clayton MM, , Choi SS, Xie G, Diehl AM, Yu DY, Feitelson MA. Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein. Cancer Res 2012;72:5912-5920.
11. Wang Y, Cui F, Lv Y, Li C, Xu X, Deng C, Wang D, Sun Y, Hu G, Lang Z, Huang C, Yang X. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 2004;39:318-324.
12. Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995;21:313-321.
13. Kong GY, Zhang JP, Zhang S, Shan CL, Ye LH, Zhang XD. Hepatitis B virus X protein promotes hepatoma cell proliferation via upregulation of MEKK2. Acta Pharmacol Sin 2011;32:1173-1180.
14. Xia LM, Huang WJ, Wu JG, Yang YB, Zhang Q, Zhou ZZ, Zhu HF, Lei P, Shen GX, Tian DA. HBx protein induces expression of MIG and increases migration of leukocytes through activation of NF-kappaB. Virology 2009;385:335-342.
15. Chung TW, Lee YC and Kim CH. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J 2004;18:1123-1125.
16. Huang WC, Chen WS, Chen YJ, Wang LY, Hsu SC, Chen CC, Hung MC. Hepatitis B virus X protein induces IKKalpha nuclear translocation via Akt-dependent phosphorylation to promote the motility of hepatocarcinoma cells. J Cell Physiol 2012;227:1446-1454.
17. Zhang F, Wang Q, Ye L, Feng Y and Zhang X. Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells. J Med Virol 2010;82:920-928.
18. Lara-Pezzi E, Majano PL, Yanez-Mo M, Gomez-Gonzalo M, Carretero M, Moreno-Otero R, Sanchez-Madrid F, Lopez-Cabrera M. Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix. J Hepatol 2001;34:409-415.
19. Gearhart TL, Bouchard MJ. The hepatitis B virus HBx protein modulates cell cycle regulatory proteins in cultured primary human hepatocytes. Virus Res 2011;155:363-367.
20. Kojima K, Takata A, Vadnais C, Otsuka M, Yoshikawa T, Akanuma M, Kondo Y, Kang YJ, Kishikawa T, Kato N, Xie Z, Zhang WJ, Yoshida H, Omata M, Nepveu A, Koike K. MicroRNA122 is a key regulator of alpha-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun 2011;2:338.
21. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009;137:1005-1017.
22. Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, Zhu Z, Jiao H, Lin J, Jiang K, Ding L, Zhang H, Cheng L, Fu H, Song Y, Jiang Y, Liu J, Wang R, Du N, Ye Q. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest 2013;123:630-645.
23. Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X, Wu Z: miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal 2013;25:439-446.
24. Yuan K, Lian Z, Sun B, Clayton MM, Ng IO, Feitelson MA. Role of miR-148a in hepatitis B associated hepatocellular carcinoma. PLoS One 2012;7:e35331.
25. Wu G, Yu F, Xiao Z, Xu K, Xu J, Tang W, Wang J, Song E. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer 2011;105:146-153.
26. Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One 2011;6:e19518.
27. Peng F, Xiao X, Jiang Y, Luo K, Tian Y, Peng M, Zhang M, Xu Y, Gong G. HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122. PLoS One 2014;9:e92998.
28. Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, Zhang L, Fan H. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Oncogene 2013;32:3296-3305.
29. Kodama K, Ogasawara N, Yoshikawa H, Murakami S. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J Virol 1985;56:978-986.
30. Zhang X, Zhang H, Ye L. Effects of hepatitis B virus X protein on the development of liver cancer. J Lab Clin Med 2006;147:58-66.
31. Wu CS, Yen CJ, Chou RH, Chen JN, Huang WC, Wu CY, Yu YL. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. Int J Cancer 2014;134:1638-1647.
32. Cui M, Wang Y, Sun B, Xiao Z, Ye L, Zhang X. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. Biochem Biophys Res Commun 2014;444:270-275.
33. Li H, Li Y, Liu D, Sun H, Liu J. miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells. Cell Physiol Biochem 2013;32:448-458.
34. Feng L, Allen NS, Simo S, Cooper JA. Cullin 5 regulates Dab1 protein levels and neuron positioning during cortical development. Genes Dev 2007;21:2717-2730.
35. Ayyub C, Sen A, Gonsalves F, Badrinath K, Bhandari P, Shashidhara LS, Krishna S, Rodrigues V. Cullin-5 plays multiple roles in cell fate specification and synapse formation during Drosophila development. Dev Dyn 2005;232:865-875.
36. Yao XL, Liu J, Lee E, Ling GS, McCabe JT. Cullin 5 gene expression in the rat cerebral cortex and hippocampus following traumatic brain injury (TBI). Neurosci Lett 2006;409:65-69.
37. Hu X, Zhang F, Liu XR, Wu YT, Ni YM. Efficacy and potential microRNA mechanism for computed tomography-guided percutaneous radiofrequency ablation of primary lung cancer and lung metastasis from liver cancer. Cell Physiol Biochem 2014;33:1261-1271.
38. Van Dort C, Zhao P, Parmelee K, Capps B, Poel A, Listenberger L, Kossoris J, Wasilevich B, Murrey D, Clare P, Burnatowska-Hledin M. VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways. Am J Physiol Cell Physiol 2003;285:C1386-1396.
39. Li Y, Schlamp CL, Poulsen GL, Jackson MW, Griep AE, Nickells RW: p53 regulates apoptotic retinal ganglion cell death induced by N-methyl-D-Aspartate. Mol Vis 2002;8:341-350.
40. Kipreos ET, Lander LE, Wing JP, He WW, Hedgecock EM: cul-1 is required for cell cycle exit in elegans and identifies a novel gene family. Cell 1996;85:829-839.
41. Lubbers J, Lewis S, Harper E, Hledin MP, Marquez GA, Johnson AE, Graves DR, Burnatowska-Hledin MA. Resveratrol enhances anti-proliferative effect of VACM-1/cul5 in T47D cancer cells. Cell Biol Toxicol 2011;27:95-105.
42. Mahrour N, Redwine WB, Florens L, Swanson SK, Martin-Brown S, Bradford WD, Staehling-Hampton K, Washburn MP, Conaway RC, Conaway JW. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J Biol Chem 2008;283:8005-8013.
43. Yasukawa T, Kamura T, Kitajima S, Conaway RC, Conaway JW, Aso T. Mammalian Elongin A complex mediates DNA-damage-induced ubiquitylation and degradation of Rpb1. EMBO J 2008;27:3256-3266.
44. Zhou J, Lu S, Yang S, Chen H, Shi H, Miao M, Jiao B. MicroRNA-127 post-Dranscriptionally downregulates Sept7 and suppresses cell growth in hepatocellular carcinoma cells. Cell Physiol Biochem 2014;33:1537-1546.
45. Dort CV, Zhao P, Parmelee K. VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways. Am J Physiol Cell Physiol 2002;285:c1386-c1396.
46. Li Y, Schlamp CL, Poulsen GL: p53 regulates apoptotic retinal ganglion cell death induced by N-methyl-Daspartate. Mol Vis 2002;8:341-350.